Metabolic Engineering for Efficient Ketocarotenoid Accumulation in the Green Microalga Chlamydomonas reinhardtii
ACS Synthetic Biology · 17.03.2023 · 12 (3) · 820-831
DOI: 10.1021/acssynbio.2c00616 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Synthetic Biology, online erschienen am 23.02.2023. Verfasst von Sofia Amendola und 7 weiteren Autor:innen. Beteiligte Einrichtung: Algae Biotechnology and Bioenergy, Faculty of Biology, Center for Biotechnology (CeBiTec), Bielefeld University, 33615 Bielefeld, Germany. Hauptthemen laut MEDLINE: Chlamydomonas reinhardtii, Microalgae. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 85 Literaturangaben. Gefördert von: Universit? degli Studi di Verona, Bundesministerium f?r Bildung und Forschung, King Abdullah University of Science and Technology.
Abstract (Originalsprache)
Astaxanthin is a valuable ketocarotenoid with various pharmaceutical and nutraceutical applications. Green microalgae harbor natural capacities for pigment accumulation due to their 2-C-methyl-d-erythritol 4-phosphate (MEP) pathway. Recently, a redesigned ß-carotene ketolase (BKT) was found to enable ketocarotenoid accumulation in the model microalga Chlamydomonas reinhardtii, and transformants exhibited reduced photoinhibition under high-light. Here, a systematic screening by synthetic transgene design of carotenoid pathway enzymes and overexpression from the nuclear genome identified phytoene synthase (PSY/crtB) as a bottleneck for carotenoid accumulation in C. reinhardtii. Increased ß-carotene hydroxylase (CHYB) activity was found to be essential for engineered astaxanthin accumulation. A combined BKT, crtB, and CHYB expression strategy resulted in a volumetric astaxanthin production of 9.5 ± 0.3 mg L-1 (4.5 ± 0.1 mg g-1 CDW) in mixotrophic and 23.5 mg L-1 (1.09 mg L-1 h-1) in high cell density conditions, a 4-fold increase compared to previous reports in C. reinhardtii. This work presents a systematic investigation of bottlenecks in astaxanthin accumulation in C. reinhardtii and the phototrophic green cell factory design for competitive use in industrial biotechnology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Algae Biotechnology and Bioenergy, Faculty of Biology, Center for Biotechnology (CeBiTec), Bielefeld University, 33615 Bielefeld, Germany.
- Genetics of Prokaryotes, Faculty of Biology, Center for Biotechnology (CeBiTec), Bielefeld University, 33615 Bielefeld, Germany.
- Department of Biotechnology, University of Verona, 37129 Verona, Italy.
- Bioengineering Program, Biological and Environmental Sciences and Engineering Division, King Abdullah University of Science and Technology (KAUST), Thuwal 23955, Kingdom of Saudi Arabia.
ORCID-Profile: Jacob S Kneip, Kyle J Lauersen, Matteo Ballottari, Thomas Baier
Förderung
- Universit? degli Studi di Verona
- Bundesministerium f?r Bildung und Forschung
- King Abdullah University of Science and Technology
- H2020 European Research Council
Zitieren
APA
Amendola, S., Kneip, J. S., Meyer, F., Perozeni, F., Cazzaniga, S., Lauersen, K. J., Ballottari, M., & Baier, T. (2023). Metabolic Engineering for Efficient Ketocarotenoid Accumulation in the Green Microalga Chlamydomonas reinhardtii. ACS Synthetic Biology, 12(3), 820-831. https://doi.org/10.1021/acssynbio.2c00616
Vancouver
Amendola S, Kneip JS, Meyer F, Perozeni F, Cazzaniga S, Lauersen KJ, et al. Metabolic Engineering for Efficient Ketocarotenoid Accumulation in the Green Microalga Chlamydomonas reinhardtii. ACS Synthetic Biology. 2023;12(3):820-831. doi:10.1021/acssynbio.2c00616
BibTeX
@article{Amendola2023,
author = {Amendola, Sofia and Kneip, Jacob S and Meyer, Florian and Perozeni, Federico and Cazzaniga, Stefano and Lauersen, Kyle J and Ballottari, Matteo and Baier, Thomas},
title = {Metabolic Engineering for Efficient Ketocarotenoid Accumulation in the Green Microalga Chlamydomonas reinhardtii},
journal = {ACS Synthetic Biology},
year = {2023},
volume = {12},
number = {3},
pages = {820--831},
doi = {10.1021/acssynbio.2c00616}
}
EUVIMED